Leerink Partners assumes coverage of Equillium with outperform rating and $6 target price
EQ•Leerink Partners assumed coverage of Equillium with an outperform rating and a $6 target price.
Related News
Rayonier Inc.: Truist Securities cuts target price to $22 from $24
RYN•
Ovintiv target price raised to $77 from $73
OVV•
Weyerhaeuser target price cut to $34 from $38 by BMO
WY•
C.H. Robinson Worldwide cut to hold from buy by Deutsche Bank
CHRW•
Hamilton Lane partners with Chubb Wealth to offer private markets funds in Hong Kong
HLNE•